1 Diagnostic Radiopharmaceuticals & Contrast Media Market Overview
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals & Contrast Media
1.2 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Type
1.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Radiopharmaceuticals
1.2.3 Contrast Media
1.3 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Application
1.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Comparison by Application: (2023-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2018-2030
1.4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales 2018-2030
1.4.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region: 2018 Versus 2022 Versus 2030
2 Diagnostic Radiopharmaceuticals & Contrast Media Market Competition by Manufacturers
2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Manufacturers (2018-2023)
2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Sites, Area Served, Product Type
2.5 Diagnostic Radiopharmaceuticals & Contrast Media Market Competitive Situation and Trends
2.5.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share by Revenue
2.5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario by Region
3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.3.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
3.3.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.4.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
3.4.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Region
3.5.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region
3.5.2 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.6.1 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
3.6.2 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.7.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
3.7.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Analysis by Type
4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2018-2023)
4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2018-2023)
4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2018-2023)
5 Global Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Analysis by Application
5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2018-2023)
5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2018-2023)
5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Amag Pharmaceuticals
6.1.1 Amag Pharmaceuticals Corporation Information
6.1.2 Amag Pharmaceuticals Description and Business Overview
6.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.1.5 Amag Pharmaceuticals Recent Developments/Updates
6.2 Bayer Healthcare
6.2.1 Bayer Healthcare Corporation Information
6.2.2 Bayer Healthcare Description and Business Overview
6.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.2.5 Bayer Healthcare Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Daiichi Sankyo
6.4.1 Daiichi Sankyo Corporation Information
6.4.2 Daiichi Sankyo Description and Business Overview
6.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.4.5 Daiichi Sankyo Recent Developments/Updates
6.5 GE Healthcare
6.5.1 GE Healthcare Corporation Information
6.5.2 GE Healthcare Description and Business Overview
6.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.5.5 GE Healthcare Recent Developments/Updates
6.6 Guerbet
6.6.1 Guerbet Corporation Information
6.6.2 Guerbet Description and Business Overview
6.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.6.5 Guerbet Recent Developments/Updates
6.7 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.7.5 Lantheus Recent Developments/Updates
6.8 Mallinckrodt
6.8.1 Mallinckrodt Corporation Information
6.8.2 Mallinckrodt Description and Business Overview
6.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.8.5 Mallinckrodt Recent Developments/Updates
6.9 Medtronic
6.9.1 Medtronic Corporation Information
6.9.2 Medtronic Description and Business Overview
6.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.9.5 Medtronic Recent Developments/Updates
6.10 Nordion
6.10.1 Nordion Corporation Information
6.10.2 Nordion Description and Business Overview
6.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.10.5 Nordion Recent Developments/Updates
7 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Cost Analysis
7.1 Diagnostic Radiopharmaceuticals & Contrast Media Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals & Contrast Media
7.4 Diagnostic Radiopharmaceuticals & Contrast Media Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Diagnostic Radiopharmaceuticals & Contrast Media Distributors List
8.3 Diagnostic Radiopharmaceuticals & Contrast Media Customers
9 Diagnostic Radiopharmaceuticals & Contrast Media Market Dynamics
9.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Trends
9.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers
9.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges
9.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints
10 Global Market Forecast
10.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals & Contrast Media by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals & Contrast Media by Type (2023-2030)
10.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals & Contrast Media by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals & Contrast Media by Application (2023-2030)
10.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals & Contrast Media by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals & Contrast Media by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
